antimicrobials II Flashcards
List the anti-mycobacterials
isoniazid, rifampin, ethambutol, pyrazinamide and streptomycin. May require addition of aminoglycosides, cycloserine and p-aminosalicylic acid
Why do you need multiple drugs for TB treatment?
synergy, mixed infections and resistant bacteria
Describe common TB treatment
isoniazid and rifampin for 6-9months. Pyrazinamide and ethambutol (or streptomycin) for first 2 months.
Structure of TB
cell wall contains mycolic acids, arabinogalactan and peptidoglycan. RNA polymerase is required for TB survival
Isoniazid MOA
Inhibits mycolic acid synthesis: isoniazid binds covalently to the adenine nucleotide of nicotinamide in enoyl-acyl carrier protein reductase-InhA. Bacteriostatic for resting organisms, bactericidal for growing mycobacteria. High selective toxicity
Isoniazid resistance
develops rapidly due to alterations in inhA and katG targets
isoniazid toxicities
INH injures neurons and hepatocytes: peripheral and optic neuritis, hepatic damage. Plus rash, fever, pregnancy category C
isoniazid uses
mycobacteria only
Rifampin (rifampacin) MOA
Inhibits DNA-dependent RNA polymerase initiation. Bactericidal. Synergistic with INH and streptomycin
Rifampin uses
TB, leprosy, H. flu
Rifampin toxicity
minor hepatotoxicity, induces CYP 450 (rifampin ramps up CYP450 but rifabutin does not). Orange body fluids.
Ethambutol MOA
Inhibits cell wall biosynthesis through arabinosyltransferase inhibition. Concentrates in lungs. Tuberculostatic, mycocidal.
Ethambutol toxicities
Optic neuritis (loss of green vision), gout (decreased renal clearance of uric acid). Renal excretion
ethambutol uses
mycobacteria only
Pyrazinamide MOA
Unknown- bactericidal. Enters cells/macrophages. Prodrug is hydrolyzed to pyrazinoic acid by pyrazinamidase (pncA). Effective at low pH in caseous lesions